The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
Abstract
Abstract: This report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), covering the years 1987–96 (January 15, 1997), analyzed data on 4898 patients who received 5362 transplants. Over the 10 yr of the study, 21.3% of the patients were under the age of 6 yr. Of the disorders that lead to end‐stage renal disease (ESRD), structural and developmental anomalies of aplasia, dysplasia, and obstructive uropathy accounted for over 1500 patients. Despite the potential therapies for focal segmental glomerulosclerosis (FSGS), there has been little change in its incidence and this lesion continues to be the most common cause of renal failure and transplantation among acquired diseases. Eighty‐nine per cent of patients with a functioning graft continue to receive cyclosporin A (CsA) 5 yr post‐transplantation, and 84% of patients continue to receive azathioprine (AZA), whereas 26% of patients receive alternate‐day steroid therapy at 4 yr post‐transplant. Thirty‐seven per cent of the living donor (LD) recipients and 47% of cadaver donor (CD) recipients were treated with the polyclonal T‐cell antibody ATG/ALG for induction, and the monoclonal T‐cell antibody, OKT3, was utilized for induction in 12% of LD patients and in 19% of CD patients. Twenty‐five per cent of the 5362 transplants (1333) have failed over the 10‐yr period. Graft survival is 90% at 1 yr and 74% at 6 yr for LD kidneys, and is 80% at 1 yr and 58% at 6 yr for CD patients. The most common cause for graft failure (30%) is chronic rejection. For recipients of LD grafts, relative risk (RR) factors for graft survival are African–American race (RR = 2.1, p<0.001) and greater than five prior transfusions (RR = 1.6, p<0.001). Prophylactic anti‐T‐cell antibody reduces the risk of graft failure (RR = 0.76, p=0.009). For recipients of cadaver kidneys, risk factors are: recipient age < 2 yr (RR = 2, p<0.001), donor age < 6 yr (RR = 1.3, p=0.005), and absence of induction T‐cell antibody (RR = 1.31, p<0.001).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VÉZINA, C., KUDELSKI, A., & SEHGAL, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,687
Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients
Opelz, G., & Henderson, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80084-4 · Cited by 648
RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTING
Calne, R. Y., Lim, S., Samaan, A., Collier, D. S. J., Pollard, S. G., White, D. J. G., & Thiru, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90417-0 · Cited by 367
Intragraft TGF-β1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy
Sharma, V. K., Bologa, R. M., Xu, G.-P., Li, B., Mouradian, J., Wang, J., Serur, D., Rao, V., & Suthanthiran, M. (1996) · Kidney International · doi:10.1038/ki.1996.185 · Cited by 188
Alexander, S. R., Arbus, G. S., Butt, K. M. H., Conley, S., Fine, R. N., Greifer, I., Gruskin, A. B., Harmon, W. E., McEnery, P. T., Nevins, T. E., et al. (1990) · Pediatric Nephrology · doi:10.1007/bf00869842 · Cited by 168
Self-citationRapamycin: A novel immunosuppressive macrolide
Sehgal, S. N., Molnar‐Kimber, K., Ocain, T. D., & Weichman, B. M. (1994) · Medicinal Research Reviews · doi:10.1002/med.2610140102 · Cited by 166
Inhibition of Human B Lymphocyte Cell Cycle Progression and Differentiation by Rapamycin
Aagaard-Tillery, K. M., & Jelinek, D. F. (1994) · Cellular Immunology · doi:10.1006/cimm.1994.1193 · Cited by 126
The Role of Growth Hormone in Modulation of the Immune Responsea
Kelley, K. W. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb40471.x · Cited by 106
Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells
KIM, H.-S., Rašková, J., Degiannis, D., & Raska, K., Jr. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06058.x · Cited by 45
Wood, M. A., & Bierer, B. E. (1994) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171742 · Cited by 21
Cited by
Kavey, R.-E. W., Allada, V., Daniels, S. R., Hayman, L. L., McCrindle, B. W., Newburger, J. W., Parekh, R. S., & Steinberger, J. (2006) · Circulation · doi:10.1161/circulationaha.106.179568 · Cited by 707
Chronic kidney disease in children: the global perspective
Warady, B. A., & Chadha, V. (2007) · Pediatric Nephrology · doi:10.1007/s00467-006-0410-1 · Cited by 606
2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
Tsubakihara, Y., Nishi, S., Akiba, T., Hirakata, H., Iseki, K., Kubota, M., Kuriyama, S., Komatsu, Y., Suzuki, M., Nakai, S., et al. (2010) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2010.00836.x · Cited by 278
Kidney Transplantation in Children
Dharnidharka, V. R., Fiorina, P., & Harmon, W. E. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1314376 · Cited by 265
Multiple-imputation for measurement-error correction
Cole, S. R., Chu, H., & Greenland, S. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl097 · Cited by 256
Metadata
- Authors
- Benfield, M. R., McDonald, R., Sullivan, E. K., Stablein, D. M., & Tejani, A.
- Venue
- Pediatric Transplantation
- Publisher
- Wiley
- Published
- 1999-05
- Volume
- 3
- Issue
- 2
- Pages
- 152-167
- ISSN
- 1397-3142 (ISSN-L)
- 1399-3046
- OpenAlex
- W2053405208
- Cited by
- 269
- References
- 11
- FWCI
- 15.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). https://app.cochat.ai/papers/10.1034/j.1399-3046.1999.00011.x
- The paper
- Benfield, M. R., McDonald, R., Sullivan, E. K., Stablein, D. M., & Tejani, A. (1999). The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatric Transplantation. https://doi.org/10.1034/j.1399-3046.1999.00011.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.